Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Axsome Thera (AXSM)

Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,848,600
  • Shares Outstanding, K 47,496
  • Annual Sales, $ 270,600 K
  • Annual Income, $ -239,240 K
  • 60-Month Beta 1.26
  • Price/Sales 14.13
  • Price/Cash Flow N/A
  • Price/Book 26.55
Trade AXSM with:

Options Overview Details

View History
  • Implied Volatility 41.72% ( +0.32%)
  • Historical Volatility 31.30%
  • IV Percentile 11%
  • IV Rank 17.84%
  • IV High 66.84% on 10/24/23
  • IV Low 36.27% on 05/16/24
  • Put/Call Vol Ratio 0.82
  • Today's Volume 1,398
  • Volume Avg (30-Day) 1,044
  • Put/Call OI Ratio 0.64
  • Today's Open Interest 17,622
  • Open Int (30-Day) 27,393

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -1.32
  • Number of Estimates 8
  • High Estimate -0.91
  • Low Estimate -1.67
  • Prior Year -1.00
  • Growth Rate Est. (year over year) -32.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
64.11 +23.12%
on 06/11/24
81.78 -3.48%
on 07/01/24
+5.50 (+7.49%)
since 05/31/24
3-Month
64.11 +23.12%
on 06/11/24
81.78 -3.48%
on 07/01/24
+4.37 (+5.86%)
since 04/02/24
52-Week
55.02 +43.46%
on 11/13/23
98.40 -19.79%
on 02/12/24
+7.07 (+9.84%)
since 06/30/23

Most Recent Stories

More News
Should You Buy This Sinking Stock on the Dip?

The biotech isn't having the best year.

AXSM : 78.93 (-2.59%)
Why Axsome Therapeutics Stock Is Sinking Today

A short-seller report is causing a sell-off of the biotech stock.

AXSM : 78.93 (-2.59%)
3 Monster Stocks in the Making You Can Buy Right Now

These stocks might not be small for too much longer.

GS : 465.61 (+0.42%)
LLY : 906.71 (-0.84%)
ALT : 6.74 (-6.39%)
AXSM : 78.93 (-2.59%)
VKTX : 51.54 (-6.83%)
Prediction: These 2 Growth Stocks Could Triple By 2030

These companies have a habit of silencing the bears.

AXSM : 78.93 (-2.59%)
SHOP : 66.06 (+2.21%)
Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript

AXSM earnings call for the period ending March 31, 2024.

AXSM : 78.93 (-2.59%)
Axsome: Q1 Earnings Snapshot

Axsome: Q1 Earnings Snapshot

AXSM : 78.93 (-2.59%)
Billionaires Are Buying These 2 Ultra-High Yield Dividend Stocks Hand Over Fist. Are They Smart Buys for Your Portfolio?

Stocks that work for billionaires aren't necessarily appropriate for every investor.

PLTR : 25.83 (-0.19%)
AXSM : 78.93 (-2.59%)
TMDX : 148.97 (-0.81%)
HTGC : 20.89 (+1.56%)
MO : 46.05 (+0.04%)
2 Under-the-Radar Growth Stocks to Consider

Don't ignore these innovative companies.

MDGL : 271.67 (-2.74%)
AXSM : 78.93 (-2.59%)
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move

The price could be right for these three biopharma stocks.

AXSM : 78.93 (-2.59%)
CRSP : 53.12 (-1.55%)
PFE : 27.83 (-1.38%)
3 Biotech Stocks to Buy and Hold for the Next 10 Years

There's a lot to like about these three drugmakers right now, and that shouldn't stop anytime soon.

CRSP : 53.12 (-1.55%)
AXSM : 78.93 (-2.59%)
AMGN : 310.77 (-0.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for the management of central nervous system (CNS), disorders for which there are limited treatment options available.

See More

Key Turning Points

3rd Resistance Point 83.10
2nd Resistance Point 82.21
1st Resistance Point 80.57
Last Price 78.93
1st Support Level 78.04
2nd Support Level 77.16
3rd Support Level 75.52

See More

52-Week High 98.40
Fibonacci 61.8% 81.83
Last Price 78.93
Fibonacci 50% 76.71
Fibonacci 38.2% 71.59
52-Week Low 55.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar